METRO HEALTHCARE BERHAD
KLSE (MYR): MHCARE (03005)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.465
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Financial
Market Cap
Market Cap
382 Million
NOSH
822 Million
Latest Quarter
Latest Quarter
30-Jun-2024 [#1]
Announcement Date
29-Aug-2024
Next Quarter
30-Sep-2024
Est. Ann. Date
29-Nov-2024
Est. Ann. Due Date
29-Nov-2024
QoQ | YoY
18.11% | 8.60%
T4Q Result
Revenue | NP to SH
47,468.000 | 6,528.000
RPS | P/RPS
5.77 Cent | 8.06
EPS | P/E | EY
0.79 Cent | 58.57 | 1.71%
DPS | DY | Payout %
0.54 Cent | 1.16% | 68.02%
NAPS | P/NAPS
0.04 | 10.50
QoQ | YoY
4.48% | 14.11%
NP Margin | ROE
13.75% | 17.91%
F.Y. | Ann. Date
30-Jun-2024 | 29-Aug-2024
Latest Audited Result
Latest Audited Result
31-Dec-2023
Announcement Date
29-Feb-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
28-Feb-2025
Est. Ann. Due Date
29-Jun-2025
Annual (Unaudited)
Revenue | NP to SH
44,686.000 | 6,248.000
RPS | P/RPS
5.43 Cent | 8.56
EPS | P/E | EY
0.76 Cent | 61.20 | 1.63%
DPS | DY | Payout %
0.52 Cent | 1.12% | 69.09%
NAPS | P/NAPS
0.05 | 10.22
YoY
22.77%
NP Margin | ROE
13.98% | 16.72%
F.Y. | Ann. Date
31-Dec-2023 | 23-Feb-2024
Annualized Result
Revenue | NP to SH
48,968.000 | 7,070.000
RPS | P/RPS
5.96 Cent | 7.81
EPS | P/E | EY
0.86 Cent | 54.08 | 1.85%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
13.16% | 8.6%
NP Margin | ROE
14.44% | 19.40%
F.Y. | Ann. Date
30-Jun-2024 | 29-Aug-2024
Business Process
| Trailing 4 Quarters | Trailing 8 Quarters | |||
|---|---|---|---|---|
| Available Quarters | 4 Quarters | 8 Quarters | ||
| Continuous Quarters Of Revenue Growth | 4 / 4 | 100.00% | 4 / 8 | 50.00% |
| Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Profit Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Adjusted EPS Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Total Dividend Years | 2 / 4 | 50.00% | 6 / 8 | 75.00% |
| Continuous Quarters Of Dividend | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Average ROE | 8.58% | 13.01% | ||
| Average Net Profit Margin | 13.58% | 16.59% | ||
| Last 5 Financial Years | Last 10 Financial Years | |||
|---|---|---|---|---|
| Available Years | 5 Years | 10 Years | ||
| Continuous Quarters Of Revenue Growth | 1 / 5 | 20.00% | 1 / 8 | 12.50% |
| Total Positive Profit Years | 5 / 5 | 100.00% | 7 / 8 | 87.50% |
| Continuous Quarters Of Positive Profit | 5 / 5 | 100.00% | 7 / 8 | 87.50% |
| Continuous Quarters Of Profit Growth | 1 / 5 | 20.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Adjusted EPS Growth | 1 / 5 | 20.00% | 1 / 8 | 12.50% |
| Total Dividend Years | 5 / 5 | 100.00% | 5 / 8 | 62.50% |
| Continuous Quarters Of Dividend | 5 / 5 | 100.00% | 5 / 8 | 62.50% |
| Continuous Quarters Of Dividend Growth | 4 / 5 | 80.00% | 4 / 8 | 50.00% |
| Continuous Quarters Of Adjusted Dps Growth | 5 / 5 | 100.00% | 5 / 8 | 62.50% |
| Average ROE | 25.28% | 18.99% | ||
| Average Net Profit Margin | 15.63% | 87.67% | ||
Key Result
| T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
|---|---|---|---|---|---|
| Revenue | 47,468 | 48,968 | 44,686 | 24,847 | 35,651 |
| NP to SH | 6,528 | 7,070 | 6,248 | 3,973 | 5,691 |
| Dividend | 4,440 | 8,880 | 4,316 | 1,576 | 2,523 |
| Adjusted EPS | 0.79 | 0.86 | 0.76 | 0.64 | 0.92 |
| Adjusted DPS | 0.54 | 1.08 | 0.52 | 0.26 | 0.41 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
Growth
| LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
|---|---|---|---|---|---|
| Revenue | 6.53% | 12.82% | 12.82% | 8.89% | 15.97% |
| NP to Owner | 18.11% | 8.60% | 8.60% | 15.44% | 1.77% |
| Dividend | 0.00% | 2.86% | 2.86% | 102.82% | 105.56% |
| Adjusted EPS | 16.33% | 7.55% | 7.55% | 14.57% | 1.01% |
| Adjusted DPS | 0.00% | 2.86% | 2.86% | 102.82% | 105.56% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
| T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.23% | 33.14% | 91.04% | 9.58% | 37.35% | 97.07% | 10.96% | 25.34% | 79.84% |
| NP to Owner | 4.48% | 14.69% | 64.29% | 13.16% | 24.21% | 77.93% | 22.77% | 9.77% | 57.25% |
| Dividend | 2.86% | 75.99% | 181.58% | 105.71% | 251.98% | 463.16% | 6.06% | 71.10% | 173.76% |
| Adjusted EPS | 4.95% | 14.81% | 64.47% | 12.87% | 23.47% | 76.88% | 21.69% | 9.39% | 56.71% |
| Adjusted DPS | 2.86% | 75.99% | 181.58% | 105.71% | 251.98% | 463.16% | 6.06% | 71.10% | 173.76% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
Discussions
Be the first to like this. Showing 16 of 15 comments
With loads of govt support and initiativea to promote ferrility treatment, which is their core strength.. this counter will only gain further
2019-10-21 21:54
this company is focused on Assisted reproductive technology with high success rate on their IVF treatment.. definitely a diamond in the making..
2021-05-27 07:48
Hurray..just received bonus share issue.. 2 for 1.. looking forward to another climb..
2021-10-23 11:54
Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$€£¥
This counter listed on IPO at 25 sen per share in 2018.
After 2 for 1 bonus, it is now 57 sen per share.
The initial investors have seen their investment per share rising from 25 sen per share to 57 x 3 = 171 sen per share (a 6 multi-bagger).
Dividends were distributed annually.
MHCare is in assisted reproductive technology. It is among the leaders providing this service in Malaysia. It benefits from health tourism which is promoted by the Malaysian government. It is growing its services in various parts of Malaysia consistently.
2022-02-15 17:46
This company is having a great run due to their focus in the niche market which involved fertility treatment coupled with their targeted expansion and coverage This has lead to a great 2H 2021 thus ending another strong full year 2021.
With a capable management who has clear objectives for strong growth and sustainability, will look forward to another grear 2022 and beyond..
2022-02-23 13:17
Saw Metro Healthcare featured in TIME Magazine Person Of The Year 2022/2023. Kudos https://link.emagazines.com/?t=6DAE8BFD-8365-47B6-A3DA-9CBA14D36A7C
2023-01-04 12:32
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
5
save malaysia!
6
Stockhistory
7
BFM Podcast
8
BFM Podcast
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
sptay
Health company specialising in women 's health and IVF.
2018-02-27 23:34